In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group
The medication works by reducing appetite
The intake quiz surfaces bundle pricing for some options but requires scheduling an appointment to see pricing for others
~ AlphaMD When most people think of testosterone, they immediately picture muscles, gym workouts, and physical strength
Oral BPC-157 is often used in studies focusing on gastrointestinal issues, like healing stomach ulcers or reducing inflammation in the gut, due to its high stability in gastric acid
That can translate into increased energy, better mood, and deeper sleep